Fifth Eye, Inc
Fifth Eye, Inc., based in Ann Arbor, MI, has developed the FDA-cleared AHI System, a groundbreaking medical device that continuously detects and predicts hemodynamic instability ahead of vital signs. This AI-driven system utilizes information from Lead II ECG signals to provide real-time surveillance of adult patients across the hospital, reducing nursing burdens and facilitating early intervention.
Designed for fast implementation and easy adoption, the AHI System offers intuitive outputs that require minimal training and provide immediate insights into patients' evolving hemodynamic trajectories. By enabling proactive patient management and timely transfer decisions, it enhances care efficiency and improves overall patient outcomes.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

